GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS

Despite a more than fifty-year period after the introduction of glucocorticoids (GCs) into therapeutic practice; they have headed the list of anti-inflammatory drugs so far. The paper analyzes current views on the terminology of GCs, mechanism of action, standardization of indications for their use...

Full description

Saved in:
Bibliographic Details
Main Authors: T. M. Reshetnyak, N. V. Seredavkina, I. S. Dydykina, E. I. Nasonov
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Klinicist
Subjects:
Online Access:https://klinitsist.abvpress.ru/Klin/article/view/6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849240160020987904
author T. M. Reshetnyak
N. V. Seredavkina
I. S. Dydykina
E. I. Nasonov
author_facet T. M. Reshetnyak
N. V. Seredavkina
I. S. Dydykina
E. I. Nasonov
author_sort T. M. Reshetnyak
collection DOAJ
description Despite a more than fifty-year period after the introduction of glucocorticoids (GCs) into therapeutic practice; they have headed the list of anti-inflammatory drugs so far. The paper analyzes current views on the terminology of GCs, mechanism of action, standardization of indications for their use in systemic lupus erythematosus, choice of a dose and a regimes of the drugs, as well as the rates of their decrease; the authors also review Russian and foreign literature on this problem and their own data.
format Article
id doaj-art-7a3c6510dc684273986832c0be406e27
institution Kabale University
issn 1818-8338
language Russian
publishDate 2014-07-01
publisher ABV-press
record_format Article
series Klinicist
spelling doaj-art-7a3c6510dc684273986832c0be406e272025-08-20T04:00:43ZrusABV-pressKlinicist1818-83382014-07-0173-4142610.17650/1818-8338-2013-3-4-14-2621GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUST. M. Reshetnyak0N. V. Seredavkina1I. S. Dydykina2E. I. Nasonov3V.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical SciencesV.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical SciencesV.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical SciencesV.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical SciencesDespite a more than fifty-year period after the introduction of glucocorticoids (GCs) into therapeutic practice; they have headed the list of anti-inflammatory drugs so far. The paper analyzes current views on the terminology of GCs, mechanism of action, standardization of indications for their use in systemic lupus erythematosus, choice of a dose and a regimes of the drugs, as well as the rates of their decrease; the authors also review Russian and foreign literature on this problem and their own data.https://klinitsist.abvpress.ru/Klin/article/view/6glucocorticoidssystemic lupus erythematosus
spellingShingle T. M. Reshetnyak
N. V. Seredavkina
I. S. Dydykina
E. I. Nasonov
GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
Klinicist
glucocorticoids
systemic lupus erythematosus
title GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
title_full GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
title_fullStr GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
title_full_unstemmed GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
title_short GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
title_sort glucocorticoids in the therapy of systemic lupus erythematosus
topic glucocorticoids
systemic lupus erythematosus
url https://klinitsist.abvpress.ru/Klin/article/view/6
work_keys_str_mv AT tmreshetnyak glucocorticoidsinthetherapyofsystemiclupuserythematosus
AT nvseredavkina glucocorticoidsinthetherapyofsystemiclupuserythematosus
AT isdydykina glucocorticoidsinthetherapyofsystemiclupuserythematosus
AT einasonov glucocorticoidsinthetherapyofsystemiclupuserythematosus